Week 9 Part 1 - ABO Discrepancies and Transfusion in Transplantation Flashcards

1
Q

ABO Grouping Discrepancies

A

An ABO discrepancy occurs when the forward and reverse grouping reactions don’t match
If blood is required before resolution of the discrepancy, issue Group O RBCs or AB plasma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What can a patient produce an anti-reagent antibody against, causing an ABO discepancy?

A

Dyes in Anti-A or Anti-B
Preservatives in reagent antibodies
Preservatives in reagent RBC preps
To prevent this - wash patient/reagent cells and resuspend in saline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

B(A) Phenotype

A

Individuals produce high concentrations of B glycosyltransferase that catalyses the addition of D-Galactose AND N-acetyl-D- galactosamine
Mostly B antigen, with weak expression of A antigen, on RBCs
Produce an anti-A antibody that agglutinates A1 and A2 RBCs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

With what antibody can the B(A) phenotype be detected?

A

Only detected when the MHO4 anti-A monoclonal antibody is used for forward grouping reactions
Solution - use a different grouping reagent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Results for B(A) Phenotype

A

Anti-A: 1+
Anti-B: 4+
A cells: 4+
B cells: 0

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Acquired B

A

Group A individuals with gut diseases (Colon Ca, septicaemia)
Bacterial deacetylases remove acetyl group from GalNAc
Some anti-B reagents bind to D-galactosamine → w+ rxn
Not a true B antigen
Solution:
- use a different anti-B reagent
- decrease pH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Acquired B Results

A

Anti-A: 3+
Anti-B: 1+
A cells: 0
B cells: 4+

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

cisAB

A

In cisAB individuals, a single allele expressing both A AND B glycosyltransferases are inherited from an AB parent, and a single allele (usually O) from the other parent
cisAB individuals have decreased glycosyltransferase production → ↓ ag expression → weak forward reactions
Usually also produce a weak anti-B antibody
- reacts with B cells but not cisAB cells
Solution - family studies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

cisAB Results

A

Anti-A: 2+
Anti-B: 2+
A cells: 0
B cells: 1+

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Chimerism

A

Patient has two different populations of RBCs present in their circulation
Can be natural or acquired

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Natural Examples of Chimerism

A

Multiple births (twins, triplets, etc)
Dispermy
Fetal-maternal bleed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Acquired Examples of Chimerism

A

Out-of-group transfusions
Bone Marrow/Stem Cell Transplants
Exchange Transfusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Chimerism - Twin Chimerism

A

Placental blood vessels anastomose between twins
Blood flows between the twins
Haematopoietic cells engraft in the BM, → 2 sets of cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Chimerism - Dispermy

A

Two sperm fertilise two maternal nuclei, and the resulting zygotes fuse to grow one body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Chimerism Results

A

Depends on the degree of the chimera
Solution:
- initially, patient history
- requires use of molecular methods to identify chimera

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Types of Transplant

A

Autologous
- cells from own body
- for those in disease remission
Allogeneic
- cells from someone else
- for patients who can’t donate their own cells (chemo, irradiation, BM disease)
Syngeneic
- cells from identical twin
- for those with identical siblings (twins, triplets, etc)
- no chance of graft rejection, GvHD

17
Q

Sources of Haematopoietic Progenitor Cells (HPCs)

A

Bone Marrow (BM)
Peripheral Blood
- collected via leukapheresis
- HPCs mobilised from BM using G-CSF (Filgrastim), Plerixafor, Chemo
Umbilical Cord Blood

18
Q

Sample Preparation

A

CD34 counts (flow)
CD34 is a marker for HPCs
BM filtered to remove fat, debris, bone fragments
Separate buffy coat from RBCs/Plasma
- cell separator or Ficoll density gradient
- can enrich for CD34+ cells (magnetic beads/FACS)

19
Q

ABO Incompatible Transplants - Major Mismatch

A

Foreign antigen on donor cells
Recipient produces antibody against donor cells
i.e. O recipient receives A cells
Recipient lyses donor RBCs, so they must be removed before transplantation

20
Q

ABO Incompatible Transplants - Minor Mismatch

A

Foreign antibody in donor sample
Donor produces antibody against recipient cells
i.e. A recipient receives O cells
Aby’s in residual donor plasma lyse recipient RBCs
Passenger lymphocyte syndrome
- donor lymphocytes are infused into recipient
- donor lymphocytes produce aby → haemolysis

21
Q

ABO Incompatible Transplants - Bi-Directional Mismatch

A

Major and minor mismatch (i.e. A recipient, B donor)

22
Q

What Happens After Transplantation - Engraftment

A

Early
- 9-30 days
- ↑ neutrophil count
Platelet engraftment
- 15+ days
RBC engraftment/reconstitution
- 90+ days

23
Q

How are RBCs and PLTs treated before being transplanted?

A

Leukoreduced and irradiated

24
Q

Example of Transfusion Support in a Major Mismatch

A

O recipient, A donor as an example
Recipient will continue to have circulating anti- A, -B, -A,B for a period of time
Donor HPCs engraft, A RBCs produced, but will be lysed until recipient aby’s are cleared, hence transfusion requirement
Gp O RBCs (recipient group) transfused until recipient aby clears
PLT/FFP contain ABO antibodies
- we don’t want to transfuse the recipient with product that will lyse donor cell
Gp A PLT/FFP (donor group) transfused

25
Q

Example of Transfusion Support in a Minor Mismatch

A

A recipient, O donor as an example
Donor HPCs engraft. Recipient RBCs eventually become group O
Gp O RBCs (donor group) transfused
PLT/FFP contain ABO antibodies
- we don’t want to transfuse the recipient with product that will lyse the recipient RBCs
Gp A PLT/FFP (recipient group) transfused

26
Q

Overview of Transfusion Support in a Major and Minor Mismatch

A

In major:
- RBCs - same group as recipient
- PLT/FFP/Plasma product - same group as donor
In minor:
- RBCs - same group as donor
- PLT/FFP/Plasma product - same group as recipient

27
Q

HSC Transplant Recipient - ABO Discrepancy with a Minor Mismatched Transplant

A

e.g. Group A recipient receives group O transplant

28
Q

HSC Transplant Recipient - ABO Discrepancy with a Major Mismatched Transplant

A

e.g. Group O recipient receives group A transplant

29
Q

Transfusion Support in ABO-Incompatible Solid Transplants

A

ABO-incompatible kidneys are transplanted
Largest concern is organ rejection due to a major mismatch
Recipient antibodies are reduced by plasmapheresis and immunosuppression
Aim in subsequent transfusions is to keep ABO antibody levels low
Blood products, particularly plasma (containing) products, must be ABO compatible with recipient AND graft for remainder of recipient’s life
Passenger lymphocyte syndrome can occur in minor mismatch recipients
- RBCs compatible with recipient and donor may be transfused to minimise this